Usop, Azhar D.

HRN: 22-96-17  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/26/2023
CEFUROXIME 1.5GM (VIAL)
04/26/2023
05/03/2023
IV
1g
Q8H
Fracture, Closed, Complete, D/3rd, Left Radius
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: